3 Sources
There has been a growing interest in the potential benefits of cannabis for individuals experiencing mood disorders. With research evolving and public perception shifting, cannabis is increasingly recognized not just for its recreational uses but also for its therapeutic potential. This story synthesizes insights from significant studies.
Read article2 Sources
Research links marijuana use to significant heart attack and stroke risks, highlighting the need for awareness of potential dangers to the cardiovascular system as legalization and recreational use rise.
Read article18min read
As marijuana use becomes legal in some states, the dominant public opinion is that marijuana is a harmless source of mood alteration. Although the harms associated with marijuana use have not been well studied, enough information is available to cause concern.
17min read
The present review will provide an overview of the neurobiology, epidemiology, clinical impact, and treatment of cannabis use disorder (CUD) in mood disorders. Patients with mood disorders including major depressive disorder (MDD) and bipolar disorder (BD) have higher rates of cannabis use, and CUD compared to the general population. Reasons for this association are not clear, nor are the putative therapeutic effects of cannabis use, or its components delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), in these illnesses. The evidence surrounding treatments for patients with this comorbidity is lacking, with more support for psychotherapeutic treatments compared with pharmacological treatments.
National Center for Biotechnology Information